The role of doxycycline in the therapy of multidrug-resistant E. coli - an in vitro study

doi:10.1038/srep31964

Chia Nan University of Pharmacy & Science Institutional Repository > 藥理學院 > 保健營養系(所) > 期刊論文 > Item 310902800/31067

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/31067

標題:	The role of doxycycline in the therapy of multidrug-resistant E. coli - an in vitro study
作者:	Lai, Chih-Cheng Chen, Chi-Chung Huang, Hui-Ling Chuang, Yin-Ching Tang, Hung-Jen
貢獻者:	Chi Mei Med Ctr, Dept Intens Care Med Chi Mei Med Ctr, Dept Med Res Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr Chi Mei Med Ctr, Dept Internal Med Chi Mei Med Ctr, Dept Med
關鍵字:	carbapenemase-producing enterobacteriaceae glycylcycline antimicrobial agent field gel-electrophoresis gram-negative bacteria klebsiella-pneumoniae escherichia-coli pseudomonas-aeruginosa combination therapy beta-lactamases infections
日期:	2016-08
上傳時間:	2018-01-18 11:41:00 (UTC+8)
出版者:	Nature Publishing Group
摘要:	This study assessed the in vitro antibacterial activity of combinations of amikacin and doxycycline or tigecycline against multidrug-resistant E. coli isolates. Twenty-four different pulsotypes, including 10 extended-spectrum beta-lactamase (ESBL)-, 10 carbapenem-resistant, 2 New Delhi Metallo-beta-lactamase (NDM)- and 2 Klebsiella pneumoniae carbapenemase (KPC)-E. coli isolates were collected. All 24 isolates were susceptible to amikacin and tigecycline. Only 30% of ESBL and 50% of carbapenem-resistant E. coli were susceptible to doxycycline. Both of the NDM-E. coli had a MIC of 64 mu g/ml. The checkerboard method showed that for the ESBL-and carbapenem-resistant E. coli, the synergistic effects of amikacin/doxycycline were 80% and 90%, respectively. For the two KPC- and two NDM-E. coli, the FIC index of amikacin/doxycycline were 0.5/0.375 and 0.5/0.281, respectively. For the ESBL- and carbapenem-resistant E. coli isolates, the combinations of amikacin and doxycycline exhibited synergistic activities against 80%, and 80% and 10% vs 60%, and 80% and 10% of the isolates at concentrations of 1x, 1/2x and 1/4xMIC, respectively. The synergistic effect seems to be similar for doxycycline and tigecycline based combinations with amikacin. In conclusion, the antibacterial activity of doxycycline can be enhanced by the addition of amikacin and is observed against most multidrug-resistant E. coli isolates.
關聯:	Scientific Reports, v.6, 31964
显示于类别:	[保健營養系(所) ] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
31067.pdf		509Kb	Adobe PDF	245	检视/开启
index.html		0Kb	HTML	1177	检视/开启

在CNU IR中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....